Golden
LoginSign Up
Synthetic Genomics (company)

Synthetic Genomics (company)

A company developing and commercializing products in biopharma, industrial biotech, and biotech lab services.

Synthetic Genomics Inc. (SGI) was founded in 2005 by J. Craig Venter and Nobel Laureate Hamilton O. Smith. The company has three core focus areas including self-amplifying RNA for vaccines and therapeutics, automated DNA and RNA production, and novel cell factories for discovery and biomanufacturing. Its subsidiary, SGI-DNA, commercializes hardware and reagents for DNA synthesis, including the world's first desktop DNA synthesizer.

Business Segments

RNA medicines

SGI-DNA

Cell factories

Synthetic Genomics has commercialized two novel organisms that have the potential to become new standard host organisms in biological research. Cmax is a microbial host capable of making proteins, including monoclonal antibodies, for therapeutic applications. It is purported to be faster, cheaper, and more scaleable than the industry standard host Chinese hamster ovary (CHO) cells.

Vmax is a microbial host capable of making a variety of molecules. It is a proprietary strain of Vibrio natriegens, which grows nearly twice as fast as Escherichia coli, a standard host organism used in biological research and some commercial applications.

Partnerships

Synthetic Genomics has publicly-announced five partnerships, including three focused on healthcare, one focused on animal health, and one focused on industrial biotechnology.

ExxonMobil

United Therapeutics

Ceva

Janssen

Novartis

Timeline

People

Name
Role
Related Golden topics

Hamilton O. Smith

Co-founder

J. Craig Venter

Co-founder

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services